
Santen Pharmaceutical Completes Share Buyback Totaling 31.90 Billion Yen

I'm PortAI, I can summarize articles.
Santen Pharmaceutical Co., Ltd. has completed its share buyback program, repurchasing 19,800,000 common shares for approximately 31.90 billion yen. The buyback was executed through open-market repurchases as per a Board of Directors resolution.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

